Healthtech Startups

The LTM Group operates a network of home health, personal care, hospice, and rehab companies delivering in-home care and partnering with health systems and payors on value-based care. It serves patients and health care providers across Indiana, Ohio, and Michigan.

1 investor

The Mole Clinic provides skin cancer detection services, including full-body skin checks and mole mapping for early identification of melanoma and non-melanoma skin cancers. The clinic serves patients in the UK seeking professional mole and skin evaluation.

1 investor

The Playbook is a sports performance app and web-based dashboard that tracks stress, well-being, and resilience to quantify mental health status for athletic organizations. It serves NCAA, professional sports leagues, and Olympic programs seeking strategic mental health care and improved athlete performance.

1 investor

The Renal Project delivers dialysis treatment services in India, combining medical expertise with quality assurance standards and technology solutions tailored to kidney care. The company serves patients in hinterland regions of India with a focus on safe, cost-effective, and effective dialysis delivery.

1 investor

Ritedose is a contract development and manufacturing organization (CDMO) that produces generic and specialty medications using advanced data analysis and custom technology solutions. The company serves patients and pharmaceutical clients by manufacturing high-quality drugs in cGMP-compliant facilities while maintaining a focus on safety, quality, and environmental sustainability.

1 investor

The Siesta Group provides computer-assisted sleep scoring and EEG biomarker extraction services, with AI-powered analysis of biometric signals for pharmaceutical and biotechnology firms. The company supports clinical trials focused on neurology therapies through centralized scoring and proprietary biomarker research tools.

1 investor

The Wound Company delivers telemedicine and in-person wound care services for patients with chronic wounds, surgical incisions, and ostomies, using certified wound care specialists to provide personalized treatment plans. The company operates a multichannel platform connecting patients to specialized wound care expertise via text, email, phone, and video visits.

1 investor

Ametris provides wearable digital health technology devices and remote monitoring platforms for clinical trials and pharmaceutical research. The company combines FDA-cleared medical-grade wearables, data processing algorithms, and operational support to help researchers capture real-world patient data across neurology, oncology, and other therapeutic areas.

1 investor

ChangeMakers is a Canadian consultancy offering PR and reputation management, social impact consulting, marketing and advertising, organizational change management, and agribusiness and international trade services. It also runs specialized practices in healthcare communications and data intelligence for clients across sectors including pharma, public policy, CPG, and finance.

1 investor

The Data Guild is a venture studio that builds companies addressing challenges in healthcare, life sciences, renewable energy, and climate change. It operates with a model of hiring "members" rather than traditional staff, drawing on an expert network to develop portfolio companies.

1 investor

The Evidence Company builds an explainable AI (XAI) platform for healthcare that quantifies its own uncertainty, traces decisions to source evidence, and flags unreliable LLM outputs so clinicians know when to trust them. Its products serve healthcare providers and care teams with uses such as AI pre-assessment intake, risk stratification, decision support, and multilingual patient communications.

1 investor

The Health Care Blog is an online publication covering the business of healthcare, health policy, medical practice, and health technology innovations. It reaches a daily audience of healthcare executives, policymakers, physicians, investors, and industry professionals.

1 investor

1 investor

TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.

1 investor

Pogaduszki is a mobile app for speech therapy (logopedic) exercises aimed at children and their parents. The company is transitioning away from its current paid in-app therapy model and preparing a new version of the app.

1 investor

MRN operates a decentralized clinical trial site network that connects trial sponsors with diverse patient populations through flexible, community-based delivery models. The platform provides participating sites with eClinical technology, staffing support, and project management to enable faster patient recruitment and retention across traditional, hybrid, and remote trial settings.

1 investor

Neolight makes the Phoenix ICON, a retinal imaging camera for medical/ophthalmic imaging that exports images to DICOM-compliant PACS via C-STORE and pulls modality worklists from PACS/RIS. It targets healthcare providers and clinical imaging workflows.

1 investor

The Pack makes vet-developed plant-based wet dog food using pea-protein-based meat analogues, sold in recyclable 375g cans across three flavours and formulated to be nutritionally complete and hypoallergenic. The products target dog owners seeking vegan, grain-free diets with lower environmental impact.

1 investor

BraceX develops a portable device enabling patients to perform eccentric strengthening exercises safely at home, addressing rehabilitation accessibility barriers for orthopedic injuries and conditions like COPD and Parkinson's Disease.

1 investor

A medtech company developing a platform focused on treating neurological conditions and neurotherapeutics. The company is currently operating in stealth mode.

1 investor

TheraCryf is developing Ox-1, a candidate-stage orexin-1 receptor antagonist molecule intended to treat substance use disorders (addictive behaviours) and anxiety. The compound is at late pre-clinical stage and funded toward regulatory submissions for Phase 1 human volunteer studies.

1 investor

ActaStim offers an FDA-approved electrical bone growth stimulation device used as an adjunct to lumbar spinal fusion surgery to improve fusion success and reduce failure rates. It is a medical device in the orthopedic/spine care category.

1 investor

Theragraph develops a visualization tool that consolidates patient data into a unified, visual interface to help physicians better manage complex patient information and care. The platform serves healthcare providers seeking to streamline patient care coordination.

1 investor

Therakos develops THERAKOS Photopheresis, an FDA-approved extracorporeal photopheresis (ECP) system used to treat skin symptoms of cutaneous T-cell lymphoma (CTCL) unresponsive to other treatments. It provides medical devices and associated drug therapy for clinicians treating CTCL patients.

1 investor